FTM posted years ago here that Bavi looks like it should be more effective in combination with radiation than chemo based on PS exposure data.
A more reasonably view here is that small biotechs have to go after the low handing fruit, and that it generally later stage trials. So a chemo trial has a shorter path to approval even if the radio combo is truly more effective.